BeStock  
Stocks › OLMA

Olema Pharmaceuticals OLMA

US equityMarket cap rank #3516
$7.94 +$0.02 (+0.25%)
Pre-market · Oct 8, 7:40 am ET · After hours $7.84 -1.32%
Open$7.90
Prev close$7.92
Day range$7.79 – $8.23
Volume819.5K
Market cap$694.73M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership118.4%-2.79 pts vs. prior quarter
Institutions holding224-2 vs. prior quarter
Insider trades (recent)23 buys / 25 sellsNet selling
Short interest18.36% of floatDays to cover 15.9 · as of 15 Sep 2026
Short-sale volume share19.4%5-day average of daily volume

Short-sale volume as % of daily volume

14%17%21%24%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.94M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

−$4.2MSuper−$748.2KBig−$1.8MMid−$1.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 47.7% of shares outstanding.

Largest holders

  • FMR13.88%
  • Paradigm Biocapital Advisors LP9.91%
  • Janus Henderson Group plc8.11%
  • Bain Capital Life Sciences Investors, LLC8.10%
  • BlackRock7.67%
  • BVF Partners L.P.6.05%
  • Artal Group S.A.5.55%
  • State Street Global Advisors4.93%

By investor type

  • Mutual Fund59.26%
  • Hedge Fund34.40%
  • VC/PE Fund17.68%
  • Public Company4.74%
  • Individual/Insider2.68%
  • Family Office/Trust1.15%
  • Private Company0.59%
  • Government Pension Fund0.36%

Reported short interest has risen from 16.07% to 18.36% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
FMR Mutual Fund 2026/Q3 +1,756,257 13.9%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +1,500,000 1.7%
Franklin Resources Mutual Fund 2026/Q3 +1,130,857 2.7%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +1,070,187 1.9%
BlackRock Mutual Fund 2026/Q3 +1,062,556 7.7%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +999,842 1.2%
Columbia Management Investment Advisers, LLC Mutual Fund 2026/Q3 +783,284 1.0%
Morgan Stanley Public Company 2026/Q3 +714,822 2.1%
Paradigm Biocapital Advisors LP Hedge Fund 2026/Q3 +650,000 9.9%
Readystate Asset Management LP Hedge Fund 2026/Q3 +593,829 0.7%
Jones Hill Capital LP Hedge Fund 2026/Q3 +574,166 0.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +566,117 1.6%
Hudson Bay Capital Management LP Hedge Fund 2026/Q3 +411,630 0.6%
State Street Global Advisors Mutual Fund 2026/Q3 +378,227 4.9%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +350,507 0.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
31 Aug 2026 Jason O'Byrne Other Derivative Acquisition +650,000 $10.56 650,000
23 Jul 2026 Cyrus Harmon Director Intent to Sell (Form 144) -12,500 $11.71 –
23 Jul 2026 Cyrus Harmon Director Open Market Disposition -25,000 $11.71 819,798
22 Jul 2026 Cyrus Harmon Director Intent to Sell (Form 144) -12,500 $11.58 –
17 Jun 2026 Andrew Rappaport Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Cynthia Butitta Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Ian T. Clark Independent Chairperson of the Board Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 BVF Partners L.P. Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Sandra Horning Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Scott Garland Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Graham L. Walmsley Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Yi Larson Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Prakash Raman Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Gorjan Hrustanovic Independent Director Other Derivative Acquisition +29,500 $9.51 29,500
17 Jun 2026 Cyrus Harmon Director Other Derivative Acquisition +29,500 $9.51 29,500
27 Apr 2026 Prakash Raman Independent Director Other Derivative Acquisition +27,061 $14.59 24,150
15 Mar 2026 Shane William Kovacs Chief Operating & Financial Officer Intent to Sell (Form 144) -100,000 $16.08 –
15 Mar 2026 Shane William Kovacs Chief Operating & Financial Officer Intent to Sell (Form 144) -4,166 $16.61 –
10 Mar 2026 Shane William Kovacs Chief Operating & Financial Officer Intent to Sell (Form 144) -50,000 $15.94 –
9 Mar 2026 Shane William Kovacs Chief Operating & Financial Officer Intent to Sell (Form 144) -53,206 $17.00 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 16,068,469 18.4% 15.9
31 Aug 2026 15,663,548 17.9% 18.5
14 Aug 2026 15,808,921 18.1% 14.3
31 Jul 2026 15,963,215 18.3% 18.2
15 Jul 2026 15,101,848 17.3% 11.3
30 Jun 2026 14,033,964 16.1% 5.7

Discussion

No comments yet — be the first to weigh in on OLMA.

Leave a comment

Scroll to Top